Ningbo Menovo Pharmaceutical Co., Ltd. Stock: price and insider trades · China
美诺华
No insider purchase over the last 90 days. The latest, by 许健配偶, was filed 27 May 2021.
Ningbo Menovo Pharmaceutical Co., Ltd.: what insiders have been doing
Ningbo Menovo Pharmaceutical Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Ningbo Menovo Pharmaceutical Co., Ltd. has had no insider filing for more than a year; the last one goes back to 27 May 2021.
Our records for Ningbo Menovo Pharmaceutical Co., Ltd. go back to 2021, with 1 purchase and 1 sale on the open market in total.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- +20.4%Entry CN¥25.34 · Close at T+365 CN¥30.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Ningbo Menovo Pharmaceutical Co., Ltd.
美诺华 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and commercialization of innovative pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
